Related Experiment Videos
Cardiac sympathetic innervation and control of potassium channel function
Journal of Molecular and Cellular Cardiology
|February 28, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PulseSelect vs FARAPULSE pulsed field ablation: Comparative analysis of myocardial, neural-injury and hemolysis biomarkers and short-term outcomes.
International journal of cardiology. Heart & vasculature·2026
Computational modeling identifies protective mechanisms of estrogen and testosterone against atrial fibrosis.
American journal of physiology. Heart and circulatory physiology·2026
Potentially futile outcome after uncomplicated TAVI: Insights from the TRITAVI registry.
American heart journal·2026
Management of dyslipidaemia in patients with comorbidities-facing the challenge: heart failure.
European heart journal. Cardiovascular pharmacotherapy·2026
Thrombo-inflammation in Cardiometabolic Disease.
The Canadian journal of cardiology·2026
PP2Acα regulates the Hippo-YAP signaling axis to promote cardiac regeneration and alleviate myocardial infarction.
Journal of molecular and cellular cardiology·2026
TMEM175 deficiency impairs autophagic degradation and alleviates mitochondrial oxidative damage in cardiomyocytes through AMPK activation.
Journal of molecular and cellular cardiology·2026
Gfpt2 modulates fibroblast activation by glutathione metabolism.
Journal of molecular and cellular cardiology·2026
Loss of Miro1 drives cardiac and mitochondrial dysfunction exacerbated by metabolic stress.
Journal of molecular and cellular cardiology·2026
Cardiometabolic stress induces HFpEF with impaired bioenergetics and disrupted proteostasis in aged female mice.
Journal of molecular and cellular cardiology·2026
Computational models show that functional remodeling, not anatomy, reshapes physiological determinants of cardiac performance in hypertrophic cardiomyopathy.
Journal of molecular and cellular cardiology·2026
Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
Journal of the American Heart Association·2026